Dr Aparna Pal

Qualifications

BM, BCh, DPhil, FRCP

GMC number: 4731351

Practicing since: 2000

Specialties

Endocrinology and Diabetes Mellitus, General (internal) Medicine

Consultation times

  • Wednesdays - 17:00 onwards
  • Overview

Or call us on

07340 505308

About

Dr Pal is a Consultant Endocrinologist and Acute Physician in Oxford and currently co-lead the busy Clinical Endocrinology Service in the Oxford Centre for Diabetes, Endocrinology and Metabolism at the Churchill Hospital. This role has enabled her to sub specialise specifically in Endocrinology and develop research interests in Pituitary Endocrinology. She does regular clinics in Pituitary, Adrenal, Thyroid and Parathyroid disorders and joint clinics with Neurosurgery and Paediatrics.

Dr Pal trained at Oxford University Medical school and qualified in 2000. She completed her specialist training in Diabetes and Endocrinology in Oxford and as part of this, achieved a PhD. She was Consultant in Diabetes and Endocrinology at the Royal Berkshire Hospital in Reading prior to her appointment in Oxford.

She has presented widely at National and International meetings and also regularly review manuscripts for publication. She has published several papers and chapters including a chapter on the Posterior Pituitary for the Oxford textbook of Medicine. She is a Clinical Tutor for Oxford University Medical School and an Examiner for the Final BM Exams. She lectures on Endocrinology for the Clinical Course and also regularly for trainees and Consultants in other medical disciplines in Oxford.


Special interests

Pituitary, Adrenal, Thyroid and Parathyroid disorders

Languages spoken

English

Treatments and tests offered by Dr Aparna Pal at Nuffield Health

  • Endocrine investigations
  • Endocrine
  • Hormone replacement therapy (HRT)
  • Blood test

Locations Dr Aparna Pal works with

Related experience

Research

Recovery of the hypothalamo-pituitary-adrenal axis following trans-sphenoidal adenomectomy for non-ACTH secreting macroadenomas.

Pofi R, Gunatilake S, Macgregor V, Shine B, Joseph R, Grossman AB, Isidori AM, Cudlip S, Jafar-Mohammadi B, Tomlinson JW, Pal A.

J Clin Endocrinol Metab. 2019 Jun 21. pii: jc.2019-00406. doi: 10.1210/jc.2019-00406.

Pituitary adenomas.

Pal A, Leaver L, Wass J.

BMJ. 2019 Jun 6;365:l2091. doi: 10.1136/bmj.l2091.

Pituitary gigantism: a rare learning opportunity.

Bendor-Samuel OM, Pal A, Cudlip S, Anderson G, Salgia S, Makaya T.

Arch Dis Child Educ Pract Ed. 2019 Apr 4. pii: edpract-2018-316282. doi: 10.1136/archdischild-2018-316282.

Plurihormonal Pit-1 lineage adenoma presenting as meningitis with recurrence after somatostatin analogue.

Olmedilla Y, Khan S, Young V, Joseph R, Cudlip S, Ansgorge O, Grossman A, Pal A.

Endocrinol Diabetes Metab Case Rep. 2019 Mar 21;2019. pii: EDM180130. doi: 10.1530/EDM-18-0130.

 Clinical, Endocrine and Imaging Characteristics of Patients with Primary Hypophysitis.

Angelousi A, Cohen C, Sosa S, Danilowicz K, Papanastasiou L, Tsoli M, Pal A, Piaditis G, Grossman A, Kaltsas G.

Horm Metab Res. 2018 Apr;50(4):296-302. doi: 10.1055/s-0044-101036. Epub 2018 Feb 19.

Transsphenoidal surgery for pituitary tumours: frequency and predictors of delayed hyponatraemia and their relationship to early readmission.

Krogh J, Kistorp CN, Jafar-Mohammadi B, Pal A, Cudlip S, Grossman A.

Eur J Endocrinol. 2018 Mar;178(3):247-253. doi: 10.1530/EJE-17-0879. Epub 2017 Dec 20.

Routine genetic screening with a multi-gene panel in patients with pheochromocytomas.

Sbardella E, Cranston T, Isidori AM, Shine B, Pal A, Jafar-Mohammadi B, Sadler G, Mihai R, Grossman AB.

Endocrine. 2018 Jan;59(1):175-182. doi: 10.1007/s12020-017-1310-9. Epub 2017 May 5.

Loss-of-Function Mutations in the Cell-Cycle Control Gene CDKN2A Impact on Glucose Homeostasis in Humans.

Pal A, Potjer TP, Thomsen SK, Ng HJ, Barrett A, Scharfmann R, James TJ, Bishop DT, Karpe F, Godsland IF, Vasen HF, Newton-Bishop J, Pijl H, McCarthy MI, Gloyn AL.

Diabetes. 2016 Feb;65(2):527-33. doi: 10.2337/db15-0602. Epub 2015 Nov 5.

The genetics of type 2 diabetes and its clinical relevance.

Pal A, McCarthy MI.

Clin Genet. 2013 Apr;83(4):297-306. doi: 10.1111/cge.12055. Epub 2012 Dec 4. Review.

PTEN mutations as a cause of constitutive insulin sensitivity and obesity.

Pal A, Barber TM, Van de Bunt M, Rudge SA, Zhang Q, Lachlan KL, Cooper NS, Linden H, Levy JC, Wakelam MJ, Walker L, Karpe F, Gloyn AL.

N Engl J Med. 2012 Sep 13;367(11):1002-11. doi: 10.1056/NEJMoa1113966.

Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.

Thanabalasingham G, Pal A, Selwood MP, Dudley C, Fisher K, Bingley PJ, Ellard S, Farmer AJ, McCarthy MI, Owen KR.

Diabetes Care. 2012 Jun;35(6):1206-12. doi: 10.2337/dc11-1243. Epub 2012 Mar 19.

Pituitary apoplexy in non-functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences.

Pal A, Capatina C, Tenreiro AP, Guardiola PD, Byrne JV, Cudlip S, Karavitaki N, Wass JA.

Clin Endocrinol (Oxf). 2011 Oct;75(4):501-4. doi: 10.1111/j.1365-2265.2011.04068.x.


Memberships

  • British Medical Association
  • Society for Endocrinology
  • Medical Protection Society

Other post held

  • Churchill and John Radcliffe Hospitals Consultant in Endocrinology and Acute Medicine

Declaration

Dr Aparna Pal does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.

Dr Aparna Pal does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.

Dr Aparna Pal does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.